Investigating embolization techniques for pelvic hemorrhage in trauma patients
Pelvic Angioembolization: A Prospective Multi-Institutional Study (Data From All Campuses Will be Used)
This study is testing different embolization techniques to see which works best for stopping pelvic bleeding in trauma patients, whether their angiograms show problems or not.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 400 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Methodist Health System Academic / other |
| Locations | 1 site (Dallas, Texas) |
| Trial ID | NCT06336889 on ClinicalTrials.gov |
What this trial studies
This multicenter prospective observational study aims to evaluate the effectiveness of embolization in patients with pelvic hemorrhage, specifically focusing on those with negative and positive angiograms. Patients will be categorized based on their angiogram results, and comparisons will be made between non-selective and selective embolization techniques. Data collected will include demographic, physiologic, and operative details, as well as outcomes related to blood transfusions and complications. The goal is to identify optimal treatment strategies for managing pelvic hemorrhage in blunt trauma patients.
Who should consider this trial
Good fit: Ideal candidates for this study are blunt trauma patients undergoing angiography for pelvic fracture associated hemorrhage.
Not a fit: Patients who are pregnant, under 18 years old, or have undergone angiography more than 24 hours after arrival will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve treatment protocols for pelvic hemorrhage, potentially reducing complications and enhancing patient outcomes.
How similar studies have performed: While the approach of embolization in trauma settings has been explored, this specific multicenter observational study may provide novel insights into treatment optimization.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • All blunt trauma patients undergoing angiography for pelvic fracture associated hemorrhage Exclusion Criteria: * • Pregnant patients * Patients \< 18 years old * Patients undergoing angiography greater than 24 hours from arrival
Where this trial is running
Dallas, Texas
- Methodist Dallas Medical Center — Dallas, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Jennifer Burris, MD — Methodist Health System
- Study coordinator: Crystee Cooper, DHEd
- Email: clinicalresearch@mhd.com
- Phone: 214-947-1280
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.